Your session is about to expire
← Back to Search
Analgesic
Arm 4 for Tension Headache
Phase 2 & 3
Waitlist Available
Research Sponsored by GlaxoSmithKline
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 8 weeks
Awards & highlights
Study Summary
This study will compare a fast-absorbing paracetamol plus caffeine formula with placebo and an over-the-counter dose of paracetamol and ibuprofen to treat episodic tension headache.
Eligible Conditions
- Tension Headache
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to First Perceptible Headache Relief
Secondary outcome measures
Headache Relief Scores
Headache Severity
Number of Participants With Complete Headache Relief
+5 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Arm 4Experimental Treatment1 Intervention
experimental paracetamol + caffeine formulation
Group II: Arm 3Active Control1 Intervention
ibuprofen marketed formulation
Group III: Arm 2Active Control1 Intervention
paracetamol marketed forumulation
Group IV: Arm 1Placebo Group1 Intervention
Placebo
Find a Location
Who is running the clinical trial?
GlaxoSmithKlineLead Sponsor
4,772 Previous Clinical Trials
8,106,837 Total Patients Enrolled
1 Trials studying Tension Headache
30 Patients Enrolled for Tension Headache
GSK Clinical TrialsStudy DirectorGlaxoSmithKline
3,596 Previous Clinical Trials
6,144,214 Total Patients Enrolled
1 Trials studying Tension Headache
30 Patients Enrolled for Tension Headache
Share this study with friends
Copy Link
Messenger